Pd35-07 Panurothelial Cell Carcinoma: Lessons LearnedNguyen, LangLippincott Williams and Wilkins2014DOI 10.1016/j.juro.2014.02.2420
Pd35-06 Can Ct Imaging Predict Stone Impaction?Parkhomenko, EgorLippincott Williams and Wilkins2017DOI 10.1016/j.juro.2017.02.1542
Pd35-12 Preoperative Factors Associated With Complications Following Radical NephroureterectomyLin, KuanLippincott Williams and Wilkins2014DOI 10.1016/j.juro.2014.02.2425
Pd35-11 Risk And Protective Factors For Recurrent Urinary Tract Infection Following Percutaneous NephrolithotomyAU, Chin-FongLippincott Williams and Wilkins2018DOI 10.1016/j.juro.2018.02.1722
PD35-04 URETEROSCOPIC LASER ABLATION OF LARGE (> 2 CM) UPPER TRACT UROTHELIAL CARCINOMAKleinmann, NirThe Journal of Urology2014DOI 10.1016/j.juro.2014.02.2417
Gentle Fire, Explorations (1970–1973), Paradigm Discs, PD35Christopher FoxCambridge University Press (CUP)2021DOI 10.1017/s0040298220001084
Pd35-09 Endoscopic Clearance Lithotripsy Devices: Comparison Of Stone Elimination Capacity And Drilling SpeedBader, MarkusLippincott Williams and Wilkins2018DOI 10.1016/j.juro.2018.02.1720
Pd35-04 Prospective Randomized Trial Of Antibiotic Prophylaxis Duration For Percutaneous Nephrolithotomy: Preliminary ResultsSamson, PatrickLippincott Williams and Wilkins2017DOI 10.1016/j.juro.2017.02.1540
Pd35-06 Vena Cavoscopy In The Assessment Of Intraluminal Vena Caval Tumor InvolvementLoh-Doyle, JeffreyLippincott Williams and Wilkins2015DOI 10.1016/j.juro.2015.02.2229
Pd35-02 Risk Factors For Blood Transfusion Following Percutaneous Nephrolithotomy In The Uk.Althaus, Adam BLippincott Williams and Wilkins2018DOI 10.1016/j.juro.2018.02.1713
Pd35-11 Cisplatin Induced Testicular Toxicity In Rats: Role Of Mesenchymal Stem Cells.Sherif, ImanLippincott Williams and Wilkins2016DOI 10.1016/j.juro.2016.02.1083
Pd35-01 The Impact Of Tumor Size On Recurrence−free Survival For Upper Tract Urothelial CarcinomaEspiritu, Patrick N.Lippincott Williams and Wilkins2014DOI 10.1016/j.juro.2014.02.2414